Press Release

Serum Free Market to be dominated by Rise in Biopharmaceutical Industries through 2027

Growing R&D for development of novel therapeutic drugs to drive the serum free market in the forecast period, 2023-2027.

According to TechSci Research report, “Serum Free Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027, the global serum free market is anticipated to grow at a significant rate in the forecast period, 2023-2027. The rising incidence of infectious and chronic diseases, demand for cell therapies for cancer treatment, and extensive research and development are the primary factors driving the demand for the global serum free market. Growing adoption of advanced technology, increasing demand for various recombinant proteins and types of culture, easier downstream processing, growing research & development for development of novel therapeutic drugs, expansion of biopharmaceutical industries and biopharma production, and heavy investments in healthcare sector are expected to influence the market demand. Also, increasing strategic growth is also a key factor for increasing the growth of the serum free market, globally.

However, the requirement of diverse cell-type for specific media formulation, and low growth rate in comparison to serum-supplemented media may hamper the growth of the global Serum Free market.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Serum Free Market"

The global serum free market is segmented into media type, end user and company.

Based on media type, the market is segmented into common serum free, xeno-free, chemically defined, protein-free, and others. The xeno-free segment is expected to hold the largest market share. This is attributed to the potential for safe use for human clinical treatment.

Based on end user, the market is divided into biotechnology & pharmaceutical companies, academic & research organizations, contract research organizations, and others. The biotechnology & pharmaceutical companies segment is anticipated to grow during the forecast period. This is attributed to rising focus on biopharmaceuticals to treat chronic diseases, high productivity, and rising drug discovery and development.

Major operating companies operating in global serum free market are:

  • Corning Incorporated
  • Lonza Group AG
  • Merck KgaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • FUJIFILM Holdings Corporation
  • PromoCell GmbH
  • Athena Environmental Sciences, Inc.
  • STEMCELL Technologies Inc.
  • Danaher Corporation
  • R&D Systems, Inc.
  • Sino Biological, Inc.
  • HiMedia Laboratories, LLC
  • PAN-Biotech GmbH
  • MP Biomedicals, LLC

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“North America region dominates the market in 2021 and is expected to maintain its dominance in the coming years due to the presence of many biopharmaceutical companies in the region. Increase in the research funding for cell and stem cell-based products, presence of a large number of leading players, strongly established research infrastructure, extensive advancements in technology, and the growing demand for serum-free media in the region is another key factor.  Also, the high number of firms with a strategic pipeline for serum-free media in the region are expected to propel the global serum free market growth till 2027” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

Serum Free Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Media Type (Common Serum Free, Xeno-Free, Chemically Defined, Protein-Free, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Contract Research Organizations, Others), By company and By Region”, has evaluated the future growth potential of global serum free market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global serum free market.

Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]

Relevant News